GEVO · NASDAQ · Chemicals - Specialty

Gevo (GEVO)

Runs an acquired North Dakota ethanol and carbon-capture plant as its main revenue engine.

$1.50
vs last close−0.06 (−4.17%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue544526294343454347
Cost of revenue233333211730242027
Gross profit2112−1282613212320
2323252623222820162628192
Research & development222210111450
111112121210111112181613
General & administrative111112121210111112181613
Other expenses111011131112169357178
Operating income−21−21−23−24−24−20−206−4−5−5−172
534332−2−3−4−1−16−5
Interest income555443211111
Interest expense111111345556
Other non-operating income−6−3−5−4−4−3−2−1−1−411−1
Income before tax−16−18−19−21−21−18−223−8−6−21−176
Net income from continuing operations−16−18−19−21−21−18−223−8−6−21−176
Net income−16−18−19−21−21−18−222−8−6−22−177
EPS, basic−$0.07−$0.08−$0.08−$0.09−$0.09−$0.07−$0.09$0.01−$0.03−$0.03−$0.09−$0.75
EPS, diluted−$0.07−$0.08−$0.08−$0.09−$0.09−$0.07−$0.09$0.01−$0.03−$0.03−$0.09−$0.75
Weighted average shares, basic240240241239239239232233233234237237
Weighted average shares, diluted240240241239239239232237233234237237
EBITDA−10−13−14−16−17−10−131456−9−164
Depreciation & amortization554436677777
EBIT−15−18−18−20−20−16−187−2−1−16−171